Smoore International (06969) has released its financial results for the first half of 2022, ending on June 30. During this period, the company had a net profit of CNY 1.385 billion, which is a decrease of 51.9% compared to the same period last year. Its basic earnings per share were CNY 0.2308. The company also plans to distribute a mid-year dividend of HKD 0.10 per share.
The company's profits in the first half of 2022 were 5.653 billion yuan, a decrease of 18.7% compared to the same period last year. Research and development (R&D) expenses increased from 236 million yuan to 604 million yuan, a growth of 155.7% compared to last year. R&D expenses as a percentage of income increased from 3.4% to 10.7% in the first half of 2022. The main reason for this increase is the company's strategy to enhance long-term competitiveness and cultivate growth opportunities in new areas. The company has continued to increase R&D investment, especially in basic research on atomization technology and in the healthcare sector.
The group will continue to strengthen market insights and gain a deep understanding of customer needs in order to adjust products and marketing strategies and help its clients succeed in market expansion and sales. With electronic atomization products, the group is leveraging its technological and manufacturing advantages to improve product delivery capabilities and respond to differentiated customer demands. The group expects a significant increase in overall revenue in the second half of this fiscal year compared to the first half.
This article contains excerpts or reposts from third-party information, which is owned by the original media and authors. If there is any infringement, please contact us for deletion. Any unit or individual who needs to repost, please contact the author and do not repost directly.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
